STOCK TITAN

Cls Holdings Usa Stock Price, News & Analysis

CLSH OTC

Welcome to our dedicated page for Cls Holdings Usa news (Ticker: CLSH), a resource for investors and traders seeking the latest updates and insights on Cls Holdings Usa stock.

CLS Holdings USA, Inc. (CLSH), operating as Cannabis Life Sciences, generates frequent news as a diversified cannabis company with integrated production, branding, and retail operations. Company updates often focus on its Oasis Cannabis dispensary in Nevada and its City Trees cultivation, production, and distribution brand, which offers cannabis concentrates and cannabis-infused products in Nevada, New Mexico, and New York.

News about CLS commonly covers operational developments and market expansion. Recent announcements have described the expansion of City Trees into new recreational markets through licensing arrangements, including entries into New Mexico and New York. The company also issues updates on new product lines and partnerships, such as collaborations to launch solventless cannabis vape products and initiatives to refresh and broaden its City Trees offerings.

CLS Holdings also releases corporate and capital structure news. Press releases have detailed debt repayment and restructuring, amendments to convertible debentures and warrants, and share repurchases linked to debt reduction. The company has additionally reported on a reverse stock split (share consolidation) and its application to voluntarily delist from the Canadian Securities Exchange, along with plans to cease being a reporting issuer in Canada.

Another recurring theme in CLS news is sustainability and packaging initiatives, including partnerships aimed at introducing certified plastic-negative packaging for its Nevada-based Oasis Cannabis dispensary. Readers following CLSH news can expect coverage of product launches, licensing-driven geographic expansion, debt and capital updates, regulatory and listing changes, and brand-focused initiatives across Oasis Cannabis and City Trees.

Rhea-AI Summary

CLS Holdings USA reported a 41% increase in revenues, reaching $11,917,629 for fiscal year 2020, up from $8,459,048 in 2019.

The gross margin expanded to 50% from 43%, indicating a 16% improvement. Customer base increased by 70.48% to 228,458.

However, the company faced a net loss of $30,657,973, largely due to a $25,185,003 non-cash goodwill impairment. Adjusted EBITDA improved, totaling ($2,082,338), compared to ($22,882,678) in the prior year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.69%
Tags
-
Rhea-AI Summary

CLS Holdings USA (OTCQB:CLSH) reported record net revenues of $1,381,842 for July 2020, marking a 44.8% increase from July 2019 and 138% from July 2018. The company's gross margin stands at 52%. Key measures to ensure health safety amidst COVID-19 were implemented, such as employee testing and sanitization. CLS has seen a significant growth trajectory since acquiring its Nevada subsidiaries, with a tripling of monthly net revenue since July 2018.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.85%
Tags
covid-19

FAQ

What is the current stock price of Cls Holdings Usa (CLSH)?

The current stock price of Cls Holdings Usa (CLSH) is $0.03605 as of July 3, 2025.

What is the market cap of Cls Holdings Usa (CLSH)?

The market cap of Cls Holdings Usa (CLSH) is approximately 5.9M.

CLSH Rankings

CLSH Stock Data

5.94M
34.49M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Las Vegas

CLSH RSS Feed